Sepsis and Innate Immunity

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 2, 2004, Pages 144-145

  Shasby, D Michael ^a   Mccray, Paul ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHELICIDIN; IMIPENEM; MESSENGER RNA; POLYMYXIN;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; ASTHMA; ATOPIC DERMATITIS; BLOOD LEVEL; BURN; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; ENDOTOXEMIA; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIGATION; MEDICAL LITERATURE; MOLECULAR EVOLUTION; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SALMONELLA; SEPSIS; SHIGELLA; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD PROTEINS; IMMUNITY, NATURAL; INTESTINES; RATS; SHEEP; SHOCK, SEPTIC;

EID: 1642534646     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2311003     Document Type: Editorial

References (13)

1. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001;7:180-185.
2. Gomez HF, Ochoa TJ, Herrera-Insua I, Carlin LG, Cleary TG. Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun 2002;70:7050-7053.
3. Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med 2002;347:1199-1200.
4. Zanetti M. Cathelicidins, multifuntional peptides of the innate immunity. J Leukoc Biol 2004;75:1-10.
5. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, Circo R, Orlando F, Skerlavaj B, Silvestri C, Saba V, et al. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock. Am J Respir Crit Care Med 2004;169:187-194.
6. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002;169:3883-3891.
7. Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002;110:823-831.
8. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 2001;167:3329-3338.
9. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-457.
10. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003;111:1665-1672.
11. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003;422:522-526.
12. Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng 2002;15:225-232.
13. Yan H, Hancock RE. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother 2001;45: 1558-1560.